Role of private providers in the implementation of the national health insurance scheme in Zambia: a qualitative study of perceptions and experiencesWarren Mukelabai Simangolwa, Jesper Sundewall
10 February 2025
Protocol for a systematic review of economic evaluations considering costs and health outcomes of weather and climate-related extreme events in humansSaeideh Babashahi, Collins Iwuji, Kingsley Orievulu, Ekeminiabasi Eyita-Okon, Dominic Kniveton
7 February 2025
Beneficiaries’ satisfaction with health insurance and associated factors in Sub-Saharan Africa: a systematic review and meta-analysisBizunesh Fantahun Kase, Abdu Hailu Shibeshi, Abubeker Alebachew Seid, Molla Getie Mehari, Abdulkerim Hassen Moloro
7 February 2025
Heterogeneous association of health with patient and general practice characteristics by region, age and chronic condition: pooled cross-sectional study of patient-level data from EnglandYan Feng, Hugh Gravelle, Vladimir Sergeevich Gordeev
7 February 2025
Counting the cost of hospitalised injury using administrative data in Australia: three considerations from a retrospective cohort data linkage studyClifford Afoakwah, Jacelle Warren, Victoria McCreanor, Shahera Banu, Michael Schuetz, Steven M McPhail, Kirsten Vallmuur
3 February 2025
Role of biosimilar introduction on insulin glargine prices: a retrospective analysis in 28 European countriesDavide Morolla, David Beran, Margaret Ewen, Mario Raviglione, Tido von Schoen-Angerer
30 January 2025
How do multiple deprivations in nuanced urban and rural settings affect health differently in South Africa? Evidence from NIDS data, 2017Msawenkosi Dlamini, Josue Mbonigaba
29 January 2025
Path analysis of factors influencing length of stay and hospitalisation expenses for oral cancer patients in tertiary hospitals in southeastern China: a cross-sectional studyYi Fan, Qiujiao Yang, Chen Chen, Xiaoying Hu, Mingming Xu, Yanfeng Weng, Yanni Li, Yaping Wang, Lisong Lin, Yu Qiu, Jing Wang, Fa Chen, Baochang He, Fengqiong Liu
25 January 2025
Behavioural factors associated with cigarette quitting behaviour: an analysis of cross-sectional survey data collected in three low-income South African communitiesSamantha Filby, Laura Rossouw
23 January 2025
Is first-line treatment with polatuzumab vedotin–rituximab–cyclophosphamide, doxorubicin and prednisone (pola-R-CHP) for previously untreated diffuse large B-cell lymphoma cost-effective in China? A cost-effectiveness analysis using a Markov modelLiangliang Dong, Wanfu Zhong, Ting Chen, Qiuling Zhao, Wenbin Liu, Xiuliang Qiu, Ruyi Huang, Shengqiang Huang, Ruixiang Xie, Lin Yang
20 January 2025
